Mobile

A placebo controlled trial of of three doses of BCX7353 to evaluate the safety and efficacy in the prevention of attacks in patients with HAE

Update Il y a 4 ans
Reference: EUCTR2015-003923-74

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

• To evaluate the efficacy of prophylactic BCX7353 at 3 doses over 28 days as measured by the frequency of attacks in subjects with hereditary angioedema (HAE)

Inclusion criteria

  • hereditary angioedema

Links